1[1]HLA T, BISHOP-BAILEY D, LIU C H, et al. Cyclooxygenase-1 and -2 isoenzymes[J]. Int J Biochem and Cell Bio, 1999, 31(5): 551-557.
2[2]ROBERTSON F M, PARRETT M L, JOARDER F S, et al. Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas[J]. Cancer Letters, 1998, 122(1～2): 165-175.
3[3]NAKATSUGI S, OHTA T, KAWAMORI T, et al. Chemoprevention by nimesulide, a selective COX-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5,6] pyridine(PhIP)-induced mammary gland carcinogenic in rats[J]. Japanese J Cancer Reserch, 2000, 91(9): 886-892.
4[4]LIU C H, CHANG S H, NARKO K, et al. Overexpression of COX-2 is sufficient to induce tumorigenesis in transgenic mice[J]. J Bio Chem, 2001, 276(21): 18 563-18 569.
5[5]TAKAHASHI Y, KAWAHARA F, NOGUCHI M, et al. Activation of matrix MMP-2 in human breast cancer cells overexpression COX-1 or -2[J]. FEBS Letters, 1999, 460(1): 145-148.
6[6]KHUDER S A, MUTGI A B. Breast cancer and NSAIDs use: a metaanalysis[J]. Bri J Cancer, 2001, 84(9): 1 188-1 192.
7[7]COTTERCHIO M, KRIEGER N, SLOAN M, et al. Non-steroidal anti-inflammatory drug use and breast cancer risk[J]. Cancer Epi Bio-markers Prev, 2001, 10(11): 1 213-1 217.
8[8]ALSHAFIE G A, ABOU-ISSA H M, SEIBERT K, et al. Chemotherapeutic evaluation of celecoxib, a COX-2 inhibitor in a rat mammary tumor model[J]. Oncol Rep, 2000, 7(6): 1 377-1 381.
9[9]SUBBARAMAIAH K, HART J C, NORTON L, et al. Microtubule-interfering agents stimulate the transcription of COX-2[J]. J Bio Chem, 2000, 275(20): 14 838-14 845.
10[10]HOWE L R, SUBBARAMAIAH K, BROWN A M C, et al. COX-2: a target for the prevention and treatment of breast cancer[J]. Endocrine-related Cancer, 2001, 8(2): 97-114.
